SWEDISH ORPHAN/S (OTCMKTS:SWTUY – Get Free Report) was down 1.2% during mid-day trading on Tuesday . The company traded as low as $24.38 and last traded at $24.38. Approximately 200 shares were traded during trading, a decline of 88% from the average daily volume of 1,665 shares. The stock had previously closed at $24.67.
SWEDISH ORPHAN/S Stock Performance
The company has a market capitalization of $6.64 billion, a PE ratio of 48.76, a PEG ratio of 1.30 and a beta of 1.81. The business’s 50-day moving average is $24.38 and its 200-day moving average is $24.38.
SWEDISH ORPHAN/S Company Profile
Swedish Orphan Biovitrum AB (publ) (OTCMKTS:SWTUY) is a Stockholm-based biopharmaceutical company specializing in the development, manufacturing and commercialization of therapies for rare diseases and specialty care. The company’s portfolio spans treatments in hematology, immunology and metabolic disorders. Its research and development efforts focus on addressing unmet medical needs by advancing both proprietary and in-licensed drug candidates through clinical and regulatory pathways.
The company’s flagship offerings include clotting factor products for hemophilia, enzyme replacement therapies for lysosomal storage disorders and targeted immunomodulators for inflammatory conditions.
Read More
- Five stocks we like better than SWEDISH ORPHAN/S
- Gravity Check: Houston, SpaceX Has a Valuation Problem
- Strategy’s Bitcoin Rally Has a Hidden Engine
- Okta’s AI Moment May Be Bigger Than Investors Realize
- 3 Rate-Ready Stocks for the New Fed Chair’s First Big Test
Receive News & Ratings for SWEDISH ORPHAN/S Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for SWEDISH ORPHAN/S and related companies with MarketBeat.com's FREE daily email newsletter.
-logo-1200x675.jpg){kind=logo}
